Findings

What do systematic reviews say?

4 questions · 4 findings · 4 reviews · Heart

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 2 · 50%High 1 · 25%

All‐cause mortality maximum · patients with coronary heart disease

Antibiotics showed no clear difference in all‐cause mortality at maximum compared with placebo or no intervention (high certainty).

1 finding from 1 review

Antibiotics for secondary prevention of coronary heart disease 2021 · Cochrane Headline outcomes only
RR 1.06 [0.99, 1.13]
20 studies · 25774 participants
High

All‐cause mortality at maximum · patients without heart failure

The intervention probably leads to lower all‐cause mortality at maximum (moderate certainty).

1 finding from 1 review

Beta‐blockers in patients without heart failure after myocardial infarction 2021 · Cochrane Headline outcomes only
RR 0.81 [0.73, 0.9]
21 studies · 22085 participants
Moderate

All‐cause mortality maximum · patients with suspected or diagnosed myocardial infarction

Beta‐blockers probably leads to lower all‐cause mortality at maximum compared with placebo or no intervention (moderate certainty).

1 finding from 1 review

Beta‐blockers for suspected or diagnosed acute myocardial infarction 2019 · Cochrane Headline outcomes only
RR 0.93 [0.86, 0.99]
21 studies · 25210 participants
Moderate

All‐cause mortality maximum · patients with acute coronary syndrome

Drug‐eluting stents showed no clear difference in all‐cause mortality at maximum compared with bare‐metal stents (low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.9 [0.78, 1.03]
21 studies · 11250 participants
Low